218 related articles for article (PubMed ID: 14762100)
1. Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.
Fiorucci S; Distrutti E; Mencarelli A; Rizzo G; Lorenzo AR; Baldoni M; Del Soldato P; Morelli A; Wallace JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):1174-82. PubMed ID: 14762100
[TBL] [Abstract][Full Text] [Related]
2. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin.
Fiorucci S; Distrutti E; Mencarelli A; Morelli A; Laufor SA; Cirino G; Wallace JL
Br J Pharmacol; 2003 Aug; 139(7):1351-9. PubMed ID: 12890715
[TBL] [Abstract][Full Text] [Related]
3. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
5. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis.
Souza MH; de Lima OM; Zamuner SR; Fiorucci S; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G54-61. PubMed ID: 12637254
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders.
Gresele P; Momi S
Cardiovasc Drug Rev; 2006; 24(2):148-68. PubMed ID: 16961726
[TBL] [Abstract][Full Text] [Related]
7. Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly.
Cezar-de-Mello PF; Nascimento-Silva V; Villela CG; Fierro IM
Oncogene; 2006 Jan; 25(1):122-9. PubMed ID: 16132039
[TBL] [Abstract][Full Text] [Related]
8. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa.
Fiorucci S; Santucci L; Wallace JL; Sardina M; Romano M; del Soldato P; Morelli A
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10937-41. PubMed ID: 12960371
[TBL] [Abstract][Full Text] [Related]
9. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
[TBL] [Abstract][Full Text] [Related]
10. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
Filep JG; Khreiss T; József L
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Papayianni A; Serhan CN; Brady HR
J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.
Medeiros R; Rodrigues GB; Figueiredo CP; Rodrigues EB; Grumman A; Menezes-de-Lima O; Passos GF; Calixto JB
Mol Pharmacol; 2008 Jul; 74(1):154-61. PubMed ID: 18413658
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Bufan B; Mojsilović S; Vucićević D; Vucević D; Vasilijić S; Balint B; Colić M
Int Immunopharmacol; 2009 Jul; 9(7-8):910-7. PubMed ID: 19341823
[TBL] [Abstract][Full Text] [Related]
14. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
Serhan CN; Clish CB; Brannon J; Colgan SP; Gronert K; Chiang N
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):643-54. PubMed ID: 11192938
[TBL] [Abstract][Full Text] [Related]
15. Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
Muzaffar S; Shukla N; Angelini G; Jeremy JY
Circulation; 2004 Aug; 110(9):1140-7. PubMed ID: 15326075
[TBL] [Abstract][Full Text] [Related]
16. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action.
Taubert D; Berkels R; Grosser N; Schröder H; Gründemann D; Schömig E
Br J Pharmacol; 2004 Sep; 143(1):159-65. PubMed ID: 15289285
[TBL] [Abstract][Full Text] [Related]
17. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
Corazzi T; Leone M; Maucci R; Corazzi L; Gresele P
J Pharmacol Exp Ther; 2005 Dec; 315(3):1331-7. PubMed ID: 16144976
[TBL] [Abstract][Full Text] [Related]
18. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.
Tesei A; Ricotti L; Ulivi P; Medri L; Amadori D; Zoli W
Int J Oncol; 2003 Jun; 22(6):1297-302. PubMed ID: 12738997
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs.
Fiorucci S; Mencarelli A; Distrutti E; Baldoni M; del Soldato P; Morelli A
J Immunol; 2004 Jul; 173(2):874-82. PubMed ID: 15240674
[TBL] [Abstract][Full Text] [Related]
20. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative.
Wallace JL; McKnight W; Del Soldato P; Baydoun AR; Cirino G
J Clin Invest; 1995 Dec; 96(6):2711-8. PubMed ID: 8675638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
